ERIN WILKINSON: Open Payments
NPI 1497383020 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,458 in 40 payments from 7 companies in 2025. Trend: 2023 $14,096 · 2024 $14,937 · 2025 $13,458
Consulting: $8,370Travel & lodging: $2,624Food & beverage: $2,464
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $11,838 |
| TG Therapeutics, Inc. | 7 | $586 |
| EMD Serono, Inc. | 5 | $508 |
| GENZYME CORPORATION | 6 | $271 |
| Biogen, Inc. | 1 | $150 |
| Celgene Corporation | 1 | $75 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
Products named: KESIMPTA, BRIUMVI, Mavenclad, TYSABRI, ZEPOSIA.
Industry payments across NV — which companies pay providers there.
